TMEM100 Regulates Neuropathic Pain by Reducing the Expression of Inflammatory Factors
There is no effective treatment for peripheral nerve injury-induced chronic neuropathic pain (NP), which profoundly impacts the quality of life of those affected. Transmembraneprotein100 (TMEM100) is considered to be a pain regulatory protein and is expressed in the dorsal root ganglion (DRG) of rat...
Saved in:
Main Authors: | Huifei Cui (Author), Zhaoyang Guo (Author), Zhu Guo (Author), Zuoran Fan (Author), Nana Shen (Author), Xiaoying Qi (Author), Yuanye Ma (Author), Youfu Zhu (Author), Xiaolin Wu (Author), Bohua Chen (Author), Hongfei Xiang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMEM Proteins in Cancer: A Review
by: Kathleen Schmit, et al.
Published: (2018) -
Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma
by: Shuai Guo, et al.
Published: (2021) -
TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
by: Karl Kunzelmann, et al.
Published: (2019) -
A Novel Homozygous Variant of TMEM231 in a Case With Hypoplasia of the Cerebellar Vermis and Polydactyly
by: Tao Wang, et al.
Published: (2021) -
Loss of phosphatidylserine flippase β-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis
by: Wenjing Liu, et al.
Published: (2021)